Tag:
King Pharmaceutical
Latest Headlines
Latest Headlines
Abuse-resistant drugs a growing niche
PharmTech.com notes that abuse-resistant pain drugs are a hot area of development right now. Author Patrician Van Arnum brings up Pfizer's recent $3.6 billion purchase of King Pharmaceuticals for its
Pfizer buys King for its 'abuse-proof' slow release technology
If you need more proof of the value of new drug delivery methods, look at this week’s news about Pfizer paying $3.6 billion to buy King Pharmaceutical. King does many things, but what made King
